REED JOHN C
CIK 1181561
Transactions on file
10
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | 2026-08-15 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Director | Grant | 647 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-15 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Exer. | 1,350 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-18 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Tax | 385 | $60.1K | +72.3% | open → |
| 2025-05-05 | 2025-05-01 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Tax | 11,002 | $1.72M | +72.2% | open → |
| 2025-05-05 | 2025-05-01 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Exer. | 25,255 | $0.00 | — | open → |
| 2026-05-04 | 2026-05-01 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Tax | 11,002 | $2.53M | +17.1% | open → |
| 2026-05-04 | 2026-05-01 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Exer. | 25,255 | $0.00 | — | open → |
| 2025-10-20 | 2025-10-17 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Sale | 21,721 | $4.19M | +39.7% | open → |
| 2025-10-20 | 2025-10-17 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Exer. | 21,721 | $3.43M | +70.4% | open → |
| 2025-07-18 | 2025-07-17 | JNJ JOHNSON & JOHNSON | Officer EVP, Innovative Medicine, R&D | Sale | 19,137 | $3.13M | +64.5% | open → |
